Article
JNK1/2 represses Lkb1-deficiency-induced lung squamous cell carcinoma progression
14 May 2019
Abstract excerpt
Mechanisms of lung squamous cell carcinoma (LSCC) development are poorly understood. Here, we report that JNK1/2 activities attenuate Lkb1-deficiency-driven LSCC initiation and progression through repressing ΔNp63 signaling. In vivo Lkb1 ablation alone is sufficient to induce LSCC development by reducing MKK7 levels and JNK1/2 activities, independent of the AMPKα and mTOR pathways. JNK1/2 activities is positively...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
